Research update · 5 October 2026

Research gaps and timeline

Functional hierarchies and relapse-sustaining cell states occur in particular tumours. Permissive transplantation and lineage-resolved state switching challenge a universal rare, fixed and irreplaceable compartment.

This dated addendum adds selected evidence and tests that could resolve the remaining questions. It does not regrade the archived review.

Questions the next study should resolve

Each question identifies a limit in the checked evidence. A missing search result alone does not establish a gap in the entire field.

How rare is tumour-sustaining capacity in the native tumour?

Competing explanation: Host permissiveness and sorting may create apparent rarity.

Discriminating test: Pair transplantation with endogenous lineage tracing; vary recipient immune status, matrix and cell viability while fixing sampling and follow-up.

Evidence: PMID 9212098 · PMID 12629218 · PMID 19052619 · PMID 22855427

Can other states replace the depleted compartment?

Competing explanation: Apparent escape may reflect incomplete ablation or true state conversion.

Discriminating test: Permanent pre-ablation lineage labels and ablation-efficiency measurement; distinguish residual target cells from converted progeny over long follow-up.

Evidence: PMID 28358093 · PMID 28355176 · PMID 32169167 · PMID 42557330

Which cell state maintains post-treatment residual disease?

Competing explanation: A relapse-specific state may differ from the primary-tumour initiating population.

Discriminating test: Track residual states after standard therapy or surgery; randomize state-specific targeting and assess relapse, not transplantation alone.

Evidence: PMID 22854781 · PMID 36352230 · PMID 41565826

Does targeting a state improve human outcomes without bypass?

Competing explanation: Off-target killing or niche alteration may produce benefit while other states replenish function.

Discriminating test: Biomarker-stratified human trials with paired biopsies, target depletion, escape-state tracking, hard outcomes and combination controls.

Evidence: PMID 28355176 · PMID 36352230 · PMID 41565826

Selected research timeline · 11 reports

Electronic publication dates are used where recorded, with issue years shown separately. This is a selected chronology, not a claim of scientific priority or independent replication for every entry.

  1. 1997

    Human acute myeloid leukemia is organized as a hierarchy that originates from a primitive hematopoietic cell.

    Human AML xenotransplantation · Issue 1997 · PMID 9212098

    A prospectively isolated compartment serially generated heterogeneous leukemia.

    What it cannot establish: Transplantation sufficiency depends on host and assay; endogenous universal necessity is separate.

  2. 2003

    Prospective identification of tumorigenic breast cancer cells.

    Human breast-cancer xenotransplantation · Online 2003-03-10; issue 2003 · PMID 12629218

    Marker-selected cells generated and serially propagated heterogeneous tumours.

    What it cannot establish: Assay selection and patient context bound the inference.

  3. 2008

    Efficient tumour formation by single human melanoma cells.

    Permissive melanoma transplantation · Issue 2008 · PMID 19052619

    Changing host/assay conditions revealed frequent tumour-forming capacity, including single-cell transplants.

    What it cannot establish: Tumour formation in a recipient does not identify an endogenous fixed hierarchy.

  4. 2012

    A restricted cell population propagates glioblastoma growth after chemotherapy.

    Mouse glioma tracing and ablation · Issue 2012 · PMID 22854781

    A relatively quiescent population sustained regrowth after chemotherapy; ablation restricted growth.

    What it cannot establish: Dependency applies to the tested model and treatment setting.

  5. 2012

    Lineage tracing reveals Lgr5+ stem cell activity in mouse intestinal adenomas.

    Mouse adenoma lineage tracing · Online 2012-08-01; issue 2012 · PMID 22855427

    Lgr5-positive cells self-renewed and generated other adenoma cells.

    What it cannot establish: Adenoma lineage behaviour does not generalize automatically to invasive carcinoma.

  6. 2017

    Visualization and targeting of LGR5+ human colon cancer stem cells.

    Human colorectal organoid tracing/ablation · Online 2017-03-29; issue 2017 · PMID 28355176

    Differentiated cells reverted and contributed to regrowth after LGR5-positive depletion.

    What it cannot establish: Organoid/xenograft plasticity is distinct from patient relapse under therapeutic targeting.

  7. 2017

    A distinct role for Lgr5+ stem cells in primary and metastatic colon cancer.

    Mouse colorectal ablation · Issue 2017 · PMID 28358093

    Lgr5-negative cells maintained primary tumours and replenished the Lgr5-positive pool.

    What it cannot establish: Primary and metastatic dependencies differed.

  8. 2020

    Plasticity of Lgr5-Negative Cancer Cells Drives Metastasis in Colorectal Cancer.

    Colorectal dissemination models · Online 2020-03-12; issue 2020 · PMID 32169167

    Lgr5-negative disseminated cells acquired stem-like capacity during metastatic outgrowth.

    What it cannot establish: Establishment and outgrowth are different causal stages.

  9. 2022

    Metastatic recurrence in colorectal cancer arises from residual EMP1+ cells.

    Post-resection colorectal mouse model · Online 2022-11-09; issue 2022 · PMID 36352230

    Residual EMP1-high cells generated recurrence; their ablation prevented relapse.

    What it cannot establish: A specific residual state and model do not establish a universal marker-defined apex.

  10. 2026

    Critical role for a high-plasticity cell state in lung cancer.

    Lung-cancer state tracing and ablation · Online 2026-01-21; issue 2026 · PMID 41565826

    A high-plasticity state contributed to progression and treatment resistance.

    What it cannot establish: State targeting and context-specific necessity do not prove irreplaceability across tumours.

  11. 2026

    ZFP36L2 orchestrates stress-adaptive plasticity in regeneration and cancer.

    Regeneration and colorectal perturbation · Online 2026-08-05; issue 2026 · PMID 42557330

    ZFP36L2 regulated stress-adaptive dedifferentiation and lineage plasticity.

    What it cannot establish: Loss of canonical stem-state entry can permit alternative malignant states.

Sources, reading depth and Methods

Case-specific Consensus records assisted gap discovery, chronology and targeted paper questions. Shared template wording about an amyloid-specific Deep follow-up is not evidence of a Deep run for this topic; the dated source records establish the actual use and access limits. Primary identifiers, selected abstract passages, correction notices and available primary-body passages were cross-checked. Generated absence cells, duplicate milestones and unsupported access claims were rejected.

Single-cell figure passage and Methods Summary P25: single cells were mixed with Matrigel and transplanted into permissive hosts; host/assay conditions are explicit.

This focused addendum does not establish 50–70 complete primary Methods/Results examinations per review. Baseline reading receipts and scores retain their original scope.

Selected full-text checks: 1; abstract checks: 10; metadata-only anchors: 0. Complete-paper examinations credited in this update: 0.

New enrichment: HSEF v5.3 causal distinctions. Archived scorecard schema: 5.4; retained as recorded.

Consensus often cited later reviews for original experimental claims. Those citations were not accepted as primary verification.

Read the dated addendum · Video script and storyboard insert · References (RIS) · References (BibTeX)